Ivermectin ameliorates bleomycin-induced lung fibrosis in male rats by inhibiting the inflammation and oxidative stress

References

• King TE, Jr., Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011; 378(9807):1949–1961. doi:10.1016/S0140-6736(11)60052-4.
   PubMed Web of Science ®Google Scholar
• Glass DS, Grossfeld D, Renna HA, et al. Idiopathic pulmonary fibrosis: current and future treatment. Clin Respir J. 2022;16(2):84–96. doi:10.1111/crj.13466.
   PubMed Web of Science ®Google Scholar
• Wolters PJ, Collard HR, Jones KD. Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol. 2014;9(1):157–179. doi:10.1146/annurev-pathol-012513-104706.
   PubMed Web of Science ®Google Scholar
• Ley B, Collard HR. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol. 2013; 5:483–492. doi:10.2147/CLEP.S54815.
   PubMedGoogle Scholar
• Spagnolo P, Sverzellati N, Rossi G, et al. Idiopathic pulmonary fibrosis: an update. Ann Med. 2015;47(1):15–27. 2015/01/02 doi:10.3109/07853890.2014.982165.
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Collard HR, Pardo A, et al. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers. 2017; 3(1):17074. doi:10.1038/nrdp.2017.74.
   PubMed Web of Science ®Google Scholar
• Bringardner BD, Baran CP, Eubank TD, et al. The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal. 2008;10(2):287–301. doi:10.1089/ars.2007.1897.
   PubMed Web of Science ®Google Scholar
• Manavi MA. Neuroprotective effects of glucagon-like peptide-1 (GLP-1) analogues in epilepsy and associated comorbidities. Neuropeptides. 2022; 94:102250. doi:10.1016/j.npep.2022.102250.
   PubMed Web of Science ®Google Scholar
• Fowlkes JL, Winkler MK. Exploring the interface between metallo-proteinase activity and growth factor and cytokine bioavailability. Cytokine Growth Factor Rev. 2002;13(3):277–287. doi:10.1016/s1359-6101(02)00005-9.
   PubMed Web of Science ®Google Scholar
• Taipale J, Keski-Oja J. Growth factors in the extracellular matrix. Faseb J. 1997;11(1):51–59. doi:10.1096/fasebj.11.1.9034166.
   PubMed Web of Science ®Google Scholar
• Winkler MK, Fowlkes JL. Metalloproteinase and growth factor interactions: do they play a role in pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol. 2002;283(1):L1–11. doi:10.1152/ajplung.00489.2001.
   PubMed Web of Science ®Google Scholar
• Wang J, Ren Y, Zheng X, et al. Anti-fibrotic effects of low toxic microcystin-RR on bleomycin-induced pulmonary fibrosis: a comparison with Microcystin-LR. Front Pharmacol. 2021;12:675907. doi:10.3389/fphar.2021.675907.
   PubMed Web of Science ®Google Scholar
• Jóna Á, Miltényi Z, Póliska S, et al. Effect of bleomycin hydrolase gene polymorphism on late pulmonary complications of treatment for Hodgkin lymphoma. PLoS One. 2016;11(6):e0157651. doi:10.1371/journal.pone.0157651.
   PubMed Web of Science ®Google Scholar
• Allawzi A, McDermott I, Delaney C, et al. Redistribution of EC-SOD resolves bleomycin-induced inflammation via increased apoptosis of recruited alveolar macrophages. Faseb J. 2019; 33(12):13465–13475. doi:10.1096/fj.201901038RR.
   PubMed Web of Science ®Google Scholar
• B BM, Lawson WE, Oury TD, et al. Animal models of fibrotic lung disease. Am J Respir Cell Mol Biol. 2013; 49(2):167–179. doi:10.1165/rcmb.2013-0094TR.
   PubMed Web of Science ®Google Scholar
• Organ L, Bacci B, Koumoundouros E, et al. Structural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis. BMC Pulm Med. 2015;15(1):81. doi:10.1186/s12890-015-0071-6.
   PubMed Web of Science ®Google Scholar
• Manavi MA, Mohammad Jafari R, Shafaroodi H, et al. Anticonvulsant effects of ivermectin on pentylenetetrazole- and maximal electroshock-induced seizures in mice: the role of GABAergic system and K(ATP) channels. Heliyon. 2022; 8(11):e11375. doi:10.1016/j.heliyon.2022.e11375.
   PubMed Web of Science ®Google Scholar
• Jourian S, Rahimi M, Manavi MA, et al. Possible interaction of opioidergic and nitrergic pathways in the anticonvulsant effect of ivermectin on pentylenetetrazole-Induced clonic seizures in mice. Neurochem Res. 2022;48(3):885–894. doi:10.1007/s11064-022-03804-9.
   PubMed Web of Science ®Google Scholar
• Tamura Y, Ozkan ED, Bole DG, et al. IPF, a vesicular uptake inhibitory protein factor, can reduce the Ca(2+)-dependent, evoked release of glutamate, GABA and serotonin. J Neurochem. 2001; 76(4):1153–1164. doi:10.1046/j.1471-4159.2001.00120.x.
   PubMed Web of Science ®Google Scholar
• Li Y, Song D, Bo F, et al. Diazepam inhibited lipopolysaccharide (LPS)-induced pyroptotic cell death and alleviated pulmonary fibrosis in mice by specifically activating GABA(A) receptor α4-subunit. Biomed Pharmacother. 2019; 118:109239. doi:10.1016/j.biopha.2019.109239.
   PubMed Web of Science ®Google Scholar
• Ma Y, Xu X, Wu H, et al. Ivermectin contributes to attenuating the severity of acute lung injury in mice. Biomed Pharmacother. 2022; 155:113706. doi:10.1016/j.biopha.2022.113706.
   PubMed Web of Science ®Google Scholar
• Chen XY, Dong YC, Yu YY, et al. Anthelmintics nitazoxanide protects against experimental pulmonary fibrosis. Br J Pharmacol. 2023;180(23):3008–3023. doi:10.1111/bph.16190.
   PubMed Web of Science ®Google Scholar
• Moeller A, Ask K, Warburton D, et al. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 2008;40(3):362–382. doi:10.1016/j.biocel.2007.08.011.
   PubMed Web of Science ®Google Scholar
• Yousefi-Manesh H, Noori T, Asgardoon MH, et al. Protective effect of dapsone against bleomycin-induced lung fibrosis in rat. Exp Mol Pathol. 2022; 124:104737. doi:10.1016/j.yexmp.2021.104737.
   PubMed Web of Science ®Google Scholar
• Zaghloul MS, Abdel-Salam RA, Said E, et al. Attenuation of bleomycin-induced pulmonary fibrosis in rats by flavocoxid treatment. Egyptian J Basic Appl Sci. 2017; 4(4):256–263. doi:10.1016/j.ejbas.2017.10.005.
   Google Scholar
• Nezamoleslami S, Sheibani M, Jahanshahi F, et al. Protective effect of dapsone against renal ischemia-reperfusion injury in rat. Immunopharmacol Immunotoxicol. 2020;42(3):272–279. doi:10.1080/08923973.2020.1755308.
   PubMed Web of Science ®Google Scholar
• Chen S, Chen H, Du Q, et al. Targeting myeloperoxidase (MPO) mediated oxidative stress and inflammation for reducing brain ischemia injury: potential application of natural compounds. Front Physiol. 2020;11:433. doi:10.3389/fphys.2020.00433.
   PubMed Web of Science ®Google Scholar
• Hübner RH, Gitter W, El Mokhtari NE, et al. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques. 2008;44(4):507–517. doi:10.2144/000112729.
   PubMed Web of Science ®Google Scholar
• Richeldi L, Azuma A, Cottin V, et al. Trial of a preferential phosphodiesterase 4B inhibitor for idiopathic pulmonary fibrosis. N Engl J Med. 2022;386(23):2178–2187. doi:10.1056/NEJMoa2201737.
   PubMed Web of Science ®Google Scholar
• Pittman JE, Skalland MS, Sagel SD, et al. Impact of azithromycin on serum inflammatory markers in children with cystic fibrosis and new Pseudomonas. J Cyst Fibros. 2022;21(6):946–949. doi:10.1016/j.jcf.2022.02.015.
   PubMed Web of Science ®Google Scholar
• Dong J, Yu X, Porter DW, et al. Common and distinct mechanisms of induced pulmonary fibrosis by particulate and soluble chemical fibrogenic agents. Arch Toxicol. 2016;90(2):385–402. doi:10.1007/s00204-015-1589-3.
   PubMed Web of Science ®Google Scholar
• Herrmann FE, Hesslinger C, Wollin L, et al. BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis. Front Pharmacol. 2022;13:838449. doi:10.3389/fphar.2022.838449.
   PubMed Web of Science ®Google Scholar
• Hussein RM, Arafa EA, Raheem SA, et al. Thymol protects against bleomycin-induced pulmonary fibrosis via abrogation of oxidative stress, inflammation, and modulation of miR-29a/TGF-β and PI3K/akt signaling in mice. Life Sci. 2023; 314:121256. doi:10.1016/j.lfs.2022.121256.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang M, Zhang WH, et al. Total flavonoids of inula japonica alleviated the inflammatory response and oxidative stress in LPS-induced acute lung injury via inhibiting the sEH activity: insights from lipid metabolomics. Phytomedicine. 2022; 107:154380. doi:10.1016/j.phymed.2022.154380.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhao S, Lai J, et al. Anti-inflammatory, antioxidant, and antifibrotic effects of Gingival-Derived MSCs on bleomycin-induced pulmonary fibrosis in mice. Int J Mol Sci. 2021; 23(1):99. doi:10.3390/ijms23010099.
   PubMed Web of Science ®Google Scholar
• Wang L, Xu WY, Tang YW, et al. Nitrative inactivation of thioredoxin-1 loses its protective effect in bleomycin-induced pulmonary fibrosis. Int Immunopharmacol. 2022; 112:109208. doi:10.1016/j.intimp.2022.109208.
   PubMed Web of Science ®Google Scholar
• Balaha M, Alahmari A, Kandeel S, et al. Vinpocetine’s immunomodulating, anti-oxidant, anti-inflammatory, ant-ifibrotic, and PDE inhibiting potencies ameliorate bleomycin-induced pulmonary fibrosis. Iran J Basic Med Sci. 2023; 26(1):13–22.
   PubMed Web of Science ®Google Scholar
• Liu H, Bai X, Wei W, et al. Calycosin ameliorates bleomycin-induced pulmonary fibrosis via suppressing oxidative stress, apoptosis, and enhancing autophagy. Evid Based Complement Alternat Med. 2022;2022:9969729.
   PubMed Web of Science ®Google Scholar
• Sgambellone S, Marri S, Catarinicchia S, et al. Adenosine A(3) receptor (A(3)AR) agonist for the treatment of bleomycin-induced lung fibrosis in mice. Int J Mol Sci. 2022;23(21):23.
   PubMed Web of Science ®Google Scholar
• Ding Y, Hou Y, Liu Y, et al. MiR-130a-3p alleviates inflammatory and fibrotic phases of pulmonary fibrosis through proinflammatory factor TNF-α and profibrogenic receptor TGF-βRII. Front Pharmacol. 2022;13:863646. doi:10.3389/fphar.2022.863646.
   PubMed Web of Science ®Google Scholar
• Shao S, Qu Z, Liang Y, et al. Iguratimod decreases bleomycin-induced pulmonary fibrosis in association with inhibition of TNF-α in mice. Int Immunopharmacol. 2021; 99:107936. doi:10.1016/j.intimp.2021.107936.
   PubMed Web of Science ®Google Scholar
• Jing F, Chen X, Xue J, et al. An herbal product alleviates bleomycin-induced pulmonary fibrosis in mice via regulating NF-κB/TNF-α signaling in macrophages. Front Pharmacol. 2022;13:805432. doi:10.3389/fphar.2022.805432.
   PubMed Web of Science ®Google Scholar
• Mouratis MA, Aidinis V. Modeling pulmonary fibrosis with bleomycin. Curr Opin Pulm Med. 2011;17(5):355–361. doi:10.1097/MCP.0b013e328349ac2b.
   PubMed Web of Science ®Google Scholar
• Carver JR, Shapiro CL, Ng A, et al. American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25(25):3991–4008. doi:10.1200/JCO.2007.10.9777.
   PubMed Web of Science ®Google Scholar
• Chen H, Luo Y, Zhu Y, et al. Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats. Front Pharmacol. 2022;13:1070736. doi:10.3389/fphar.2022.1070736.
   PubMed Web of Science ®Google Scholar
• Pei Z, Qin Y, Fu X, et al. Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model. Redox Biol. 2022;57:102509. doi:10.1016/j.redox.2022.102509.
   PubMed Web of Science ®Google Scholar
• Watson AH. GABA- and glycine-like immunoreactivity in axons and dendrites contacting the Central terminals of rapidly adapting glabrous skin afferents in rat spinal cord. J Comp Neurol. 2003; 464(4):497–510. doi:10.1002/cne.10812.
   PubMed Web of Science ®Google Scholar
• Hosseini R, Fakhraei N, Malekisarvar H, et al. Effect of sumatriptan on acetic acid-induced experimental colitis in rats: a possible role for the 5-HT(1B/1D) receptors. Naunyn Schmiedebergs Arch Pharmacol. 2022;395(5):563–577. doi:10.1007/s00210-022-02215-5.
   PubMed Web of Science ®Google Scholar
• Aryannejad A, Noroozi N, Tavangar SM, et al. Involvement of cannabinoid type 2 receptors in the favorable effects of sumatriptan on the Random-Pattern skin flap survival in rats: a novel potential target. Eur Surg Res. 2022;63(4):203–210. doi:10.1159/000521581.
   PubMed Web of Science ®Google Scholar
• Ala M, Ghasemi M, Mohammad Jafari R, et al. Beyond its anti-migraine properties, sumatriptan is an anti-inflammatory agent: a systematic review. Drug Dev Res. 2021;82(7):896–906. doi:10.1002/ddr.21819.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Ye W, Liu Y, et al. S-allylmercapto-N-acetylcysteine ameliorates pulmonary fibrosis in mice via Nrf2 pathway activation and NF-κB, TGF-β1/Smad2/3 pathway suppression. Biomed Pharmacother. 2023; 157:114018. doi:10.1016/j.biopha.2022.114018.
   PubMed Web of Science ®Google Scholar
• Elhady SS, Goda MS, Mehanna ET, et al. Meleagrin isolated from the Red Sea fungus Penicillium chrysogenum protects against bleomycin-induced pulmonary fibrosis in mice. Biomedicines. 2022;10(5):1164. doi:10.3390/biomedicines10051164.
   PubMed Web of Science ®Google Scholar
• Karamalakova Y, Stefanov I, Georgieva E, et al. Pulmonary protein oxidation and oxidative stress modulation by lemna minor L. in progressive bleomycin-induced idiopathic pulmonary fibrosis. Antioxidants (Basel). 2022;11(3):523–543. doi:10.3390/antiox11030523.
   PubMedGoogle Scholar
• Wang X, Wang Z, Tang D. Aerobic exercise alleviates inflammation, oxidative stress, and apoptosis in mice with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2021;16:1369–1379. doi:10.2147/COPD.S309041.
   PubMed Web of Science ®Google Scholar
• Huang J, Tong X, Zhang L, et al. Hyperoside attenuates bleomycin-induced pulmonary fibrosis development in mice. Front Pharmacol. 2020;11:550955. doi:10.3389/fphar.2020.550955.
   PubMed Web of Science ®Google Scholar
• Jiang J, Kao TC, Hu S, et al. Protective role of baicalin in the dynamic progression of lung injury to idiopathic pulmonary fibrosis: a meta-analysis. Phytomedicine. 2023;14:154777. doi:10.1016/j.phymed.2023.154777.
   Google Scholar
• Zhang T, Yang F, Dai X, et al. Role of caveolin-1 on the molybdenum and cadmium exposure induces pulmonary ferroptosis and fibrosis in the sheep. Environ Pollut. 2023;334:122207. doi:10.1016/j.envpol.2023.122207.
   PubMed Web of Science ®Google Scholar
• Arafa MH, Mohamed DA, Atteia HH. Ameliorative effect of N-acetyl cysteine on alpha-cypermethrin-induced pulmonary toxicity in male rats. Environ Toxicol. 2015;30(1):26–43. doi:10.1002/tox.21891.
   PubMed Web of Science ®Google Scholar
• Alghamdi HA, Al-Zharani M, Aljarba NH, et al. Efficacy of ivermectin against Colon cancer induced by dimethylhydrazine in male wistar rats. Saudi Pharm J. 2022;30(9):1273–1282. doi:10.1016/j.jsps.2022.06.024.
   PubMed Web of Science ®Google Scholar
• Abu Hafsa SH, Senbill H, Basyony MM, et al. Amelioration of sarcoptic Mange-Induced oxidative stress and growth performance in ivermectin-treated growing rabbits using turmeric extract supplementation. Animals (Basel). 2021;11(10):2983–2996. doi:10.3390/ani11102984.
   PubMedGoogle Scholar
• Rahbar A, Shakyba S, Ghaderi M, et al. Ivermectin-functionalized multiwall carbon nanotube enhanced the locomotor activity and neuropathic pain by modulating M1/M2 macrophage and decrease oxidative stress in rat model of spinal cord injury. Heliyon. 2021;7(6):e07311. doi:10.1016/j.heliyon.2021.e07311.
   PubMed Web of Science ®Google Scholar
• Tabary M, Aryannejad A, Noroozi N, et al. Ivermectin increases random-pattern skin flap survival in rats: the novel role of GABAergic system. J Surg Res. 2021; 259:431–441. doi:10.1016/j.jss.2020.09.010.
   PubMed Web of Science ®Google Scholar
• Aryannejad A, Tabary M, Noroozi N, et al. Anti-inflammatory effects of ivermectin in the treatment of acetic Acid-Induced colitis in rats: involvement of GABA(B) Receptors. Dig Dis Sci. 2022; 67(8):3672–3682. doi:10.1007/s10620-021-07258-x.
   PubMed Web of Science ®Google Scholar